Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Journal of Virology|March 30, 2004
Role of minority populations of human immunodeficiency virus type 1 in the evolution of viral resistance to protease inhibitorsCharlotte Charpentier, Dominic E Dwyer, Fabrizio Mammano, et al.American Journal of Respiratory and Critical Care Medicine|November 27, 2002
Three-dimensional characterization of pathologic lesions in pulmonary langerhans cell histiocytosisMarianne Kambouchner, Francoise Basset, Joelle Marchal, et al.Journal of Virology|March 16, 2006
Functional central polypurine tract provides downstream protection of the human immunodeficiency virus type 1 genome from editing by APOBEC3G and APOBEC3BSebastien Wurtzer, Armelle Goubard, Fabrizio Mammano, et al.Retrovirology|March 4, 2008
Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma virusesTamara Nora, Francine Bouchonnet, Béatrice Labrosse, et al.AIDS (London, England)|March 28, 2003
Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populationsKatharina Skrabal, Virginie Trouplin, Béatrice Labrosse, et al.Nature|January 28, 2005
APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retrovirusesCécile Esnault, Odile Heidmann, Frédéric Delebecque, et al.Journal of Virology|December 23, 2004
Quantification of the effects on viral DNA synthesis of reverse transcriptase mutations conferring human immunodeficiency virus type 1 resistance to nucleoside analoguesFrancine Bouchonnet, Elisabeth Dam, Fabrizio Mammano, et al.Journal of Virology|June 3, 2011
Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoformsEmilie Battivelli, Julie Migraine, Denise Lecossier, et al.Infection and Immunity|July 16, 2002
Disruption of the gene homologous to mammalian Nramp1 in Mycobacterium tuberculosis does not affect virulence in miceNeio Boechat, Béatrice Lagier-Roger, Stéphanie Petit, et al.Plos Pathogens|March 21, 2009
Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness lossElisabeth Dam, Romina Quercia, Bärbel Glass, et al.Pageof 3